Brain region-specific expression of Fxyd1, an Mecp2 target gene, is regulated by epigenetic mechanisms

Journal of Neuroscience Research

Volumn 89, Issue 6, 2011, Pages 840-851

  Banine, Fatima ^a   Matagne, Valerie ^a   Sherman, Larry S ^a   Ojeda, Sergio R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

DNA methylation; Histone acetylation; Phospholemman; Rett syndrome

Indexed keywords

GENOMIC DNA; HISTONE H3; LYSINE; MEMBRANE PROTEIN; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; PROTEIN FXYD1A; PROTEIN FXYD1B; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HISTONE METHYLATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

ANIMALS; BRAIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; HISTONES; MEMBRANE PROTEINS; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; RNA, MESSENGER;

EID: 79954610455     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22608     Document Type: Article

References (69)

1. Armstrong D, Dunn JK, Antalffy B, Trivedi R. 1995. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 54: 195-201.
2. Armstrong DD, Dunn K, Antalffy B. 1998. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 57: 1013-1017.
3. Belichenko NP, Belichenko PV, Li HH, Mobley WC, Francke U. 2008. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. J Comp Neurol 508: 184-195.
4. Belichenko PV, Dahlstrom A. 1995. Studies on the 3-dimensional architecture of dendritic spines and varicosities in human cortex by confocal laser scanning microscopy and Lucifer yellow microinjections. J Neurosci Methods 57: 55-61.
5. Belichenko PV, Hagberg B, Dahlstrom A. 1997. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 93: 50-61.
6. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi Y. 2009. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 18: 2431-2442.
7. Berger SL. 2007. The complex language of chromatin regulation during transcription. Nature 447: 407-412.
8. Bernstein BE, Meissner A, Lander ES. 2007. The mammalian epigenome. Cell 128: 669-681.
9. Bienvenu T, Chelly J. 2006. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat Rev Genet 7: 415-426.
10. Bienvenu T, Carrié A, de Roux N, Vinet M-C, Jonveaux P, Cuvert P, Villard L, Arzimanoglou A, Beldjord C, Fontes M, Tardieu M, Chelly J. 2000. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet 9: 1377-1384.
11. Bjornsson HT, Fallin MD, Feinberg AP. 2004. An integrated epigenetic and genetic approach to common human disease. Trends Genet 20: 350-358.
12. Bogaev RC, Jia LG, Kobayashi YM, Palmer CJ, Mounsey JP, Moorman JR, Jones LR, Tucker AL. 2001. Gene structure and expression of phospholemman in mouse. Gene 271: 69-79.
13. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107.
14. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304.
15. Chahrour M, Zoghbi HY. 2007. The story of Rett syndrome: from clinic to neurobiology. Neuron 56: 422-437.
16. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. 2008. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229.
17. Chang Q, Khare G, Dani V, Nelson S, Jaenisch R. 2006. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49: 341-348.
18. Chen C, Yang MC, Yang TP. 2001. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. J Biol Chem 276: 320-328.
19. Chen RZ, Akbarian S, Tudor M, Jaenisch R. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 327: 331.
20. Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith C, Jaenisch R, Greenberg ME. 2003. Depression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889.
21. Crambert G, Füzesi M, Garty H, Karlish S, Geering K. 2002. Phospholemman (FXYD1) associates with Na, K-ATPase and regulates its transport properties. Proc Natl Acad Sci U S A 99: 11476-11481.
22. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S, Pevsner J, Dissen GA, Sherman LS, Ojeda SR. 2007. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 16: 640-650.
23. Dillon N. 2006. Gene regulation and large-scale chromatin organization in the nucleus. Chromosome Res 14: 117-126.
24. Feschenko MS, Donnet C, Wetzel RK, Asinovski NK, Jones LR, Sweadner KJ. 2003. Phospholemman, a single-span membrane protein, is an accessory protein of Na, K-ATPase in cerebellum and choroid plexus. J Neurosci 23: 2161-2169.
25. Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y. 2005. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64: 537-544.
26. +-ATPase activity, facilitates female sexual development by maintaining GnRH neuronal excitability. J Neuroendocrinol 21: 108-122.
27. Graveley BR. 2001. Alternative splicing: Increasing diversity in the proteomic world. Trends Genet 17: 100-107.
28. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES. 2009. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458: 223-227.
29. Guy J, Hendrich B, Holmes M, Martin JE, Bird A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326.
30. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37: 31-40.
31. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245-254.
32. Jordan C, Li HH, Kwan HC, Francke U. 2007. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 8: 36.
33. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, Benes V, Gannon F, Reid G. 2008. Transient cyclical methylation of promoter DNA. Nature 452: 112-115.
34. Khorasanizadeh S. 2004. The nucleosome: from genomic organization to genomic regulation. Cell 116: 259-272.
35. Kishi N, Macklis JD. 2004. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27: 306-321.
36. Kishi N, Macklis JD. 2005. Dissecting MECP2 function in the central nervous system. J Child Neurol 20: 753-759.
37. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP. 2005. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19: 667-678.
38. Koch CM, Andrews RM, Flicek P, Dillon SC, Karaoz U, Clelland GK, Wilcox S, Beare DM, Fowler JC, Couttet P, James KD, Lefebvre GC, Bruce AW, Dovey OM, Ellis PD, Dhami P, Langford CF, Weng Z, Birney E, Carter NP, Vetrie D, Dunham I. 2007. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res 17: 691-707.
39. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705.
40. Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. 2006. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 26: 5033-5042.
41. Kriventseva EV, Koch I, Apweiler R, Vingron M, Bork P, Gelfand MS, Sunyaev S. 2003. Increase of functional diversity by alternative splicing. Trends Genet 19: 124-128.
42. Lee BM, Mahadevan LC. 2009. Stability of histone modifications across mammalian genomes: implications for "epigenetic" marking. J Cell Biochem 108: 22-34.
43. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R. 2004. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A 101: 6033-6038.
44. Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE. 2003. DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 302: 890-893.
45. Matarazzo V, Ronnett GV. 2004. Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency. Proc Natl Acad Sci U S A 101: 7763-7768.
46. McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY. 2006. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 103: 18267-18272.
47. Metivier R, Gallais R, Tiffoche C, Le PC, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, Benes V, Jeltsch A, Gannon F, Salbert G. 2008. Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
48. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560.
49. Miller CA, Sweatt JD. 2007. Covalent modification of DNA regulates memory formation. Neuron 53: 857-869.
50. Mounsey JP, Lu KP, Patel MK, Chen ZH, Horne LT, John JEIII, Means AR, Jones LR, Moorman JR. 1999. Modulation of Xenopus oocyte-expressed phospholemman-induced ion currents by co-expression of protein kinases. Biochim Biophys Acta 1451: 305-318.
51. Mounsey JP, John JEI, Helmke SM, Such EW, Gilbert J, Roses AD, Perrymann MB, Jones LR, Moorman JR. 2000. Phospholemman is a substrate for myotonic dystrophy protein kinase. J Biol Chem 275: 23362-23367.
52. Mullaney BC, Johnston MV, Blue ME. 2004. Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 123: 939-949.
53. Nagane Y, Utsugisawa K, Tohgi H. 2000. PCR amplification in bisulfite methylcytosine mapping in the GC-rich promoter region of amyloid precursor protein gene in autopsy human brain. Brain Res Protoc 5: 167-171.
54. Nan X, Meehan RR, Bird A. 1993. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res 21: 4886-4892.
55. Nuber UA, Kriaucionis S, Roloff TC, Guy J, Selfridge J, Steinhoff C, Schulz R, Lipkowitz B, Ropers HH, Holmes MC, Bird A. 2005. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 14: 2247-2256.
56. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H, Tempst P, Lin SP, Allis CD, Cheng X, Bestor TH. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714-717.
57. Palmer CJ, Scott BT, Jones LR. 1991. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266: 11126-11130.
58. Peddada S, Yasui DH, LaSalle JM. 2006. Inhibitors of differentiation (ID1, ID2, ID3, and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 15: 2003-2014.
59. Presti DF, Jones LR, Lindemann JP. 1985. Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem 260: 3860-3867.
60. Ruthenburg AJ, Li H, Patel DJ, Allis CD. 2007. Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8: 983-994.
61. Schwartz YB, Pirrotta V. 2007. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22.
62. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. 2002a. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115-124.
63. Shahbazian MD, Young JI, Yuva-Paylor LA, Spencer CM, Antalffy BA, Noebels JL, Armstrong DL, Paylor R, Zoghbi HY. 2002b. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35: 243-254.
64. Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP. 2010. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 37: 457-468.
65. Tudor M, Akbarian S, Chen RZ, Jaenisch R. 2002. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99: 15536-15541.
66. Walaas SI, Horn RS, Albert KA, Adler A, Walaas O. 1988. Phosphorylation of multiple sites in a 15, 000 dalton proteolipid from rat skeletal muscle sarcolemma, catalyzed by adenosine 3', 5'-monophosphate-dependent and calcium/phospholipid-dependent protein kinases. Biochim Biophys Acta 968: 127-137.
67. Walaas SI, Czernik AJ, Olstad OK, Sletten K, Walaas O. 1994. Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenalin-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J 304: 635-640.
68. Wan M, Lee SS, Zhang X, Houwink-Manville I, Song HR, Amir RE, Budden S, Naidu S, Pereira JL, Lo IF, Zoghbi HY, Schanen NC, Francke U. 1999. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet 65: 1520-1529.
69. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K. 2008. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40: 897-903.